SRPT · Stage, GEX levels and seasonality

Sarepta Therapeutics,, Inc. Common Stock (SRPT)

Last close $18.22 (-2.25%) on 2026-09-30

Start 7-day trial

No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.

Open the chart

Weinstein stage

Stage 1B — Basing · 3 weeks in this stage · 30-week average $18.58

Stage 1 (basing): price moves sideways around a flattening 30-week average after a decline.

What would change it: Stage 2 begins on a weekly close above 23.62 (base high) with price above the 30-week SMA, ideally on at least 2× average volume.

GEX levels

Call wall, put wall and gamma flip for SRPT are on Signa plans. What GEX levels tell you.

Seasonality

MonthAverage returnMonths upYears
January+0.77%25%4
February+3.28%50%4
March-5.3%50%4
April+0.38%50%4
May-14.63%25%4
June-7.61%50%4
July-13.16%0%4
August+19.12%75%4
September-2.7%25%4
October (this month)-9.06%67%3
November+1.76%67%3
December+2.92%33%3

Based on up to 4 years of weekly closes. Past seasonality does not predict future returns.

On Signa plans

The Signa score and Action Card for SRPT, live options flow, dark pool prints, today's GEX levels with vanna and charm, and what 40+ AI agents say about it.

Start 7-day trial

No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.

Questions about SRPT

What Weinstein stage is SRPT in?

SRPT is in Stage 1B — Basing, for 3 weeks, based on completed weekly bars and its 30-week moving average (18.58).

How has SRPT done in October?

Over the last 3 years, SRPT averaged -9.06% in October and rose in 67% of them. Past seasonality does not predict future returns.

Start 7-day trial

No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.